Inonotus obliquus, sold almost everywhere as chaga mushroom, is a circumboreal white-rot fungus that lives inside birch and erupts through the bark as a cracked black mass. That mass is not a cap. It is a sterile sclerotium — a hardened storage organ — and it is what people harvest, powder, and boil. The actual fruiting body appears later, once, under the bark of a dead host, and most foragers never see it. The species is accepted under that name by Index Fungorum, NCBI Taxonomy, and Catalogue of Life. Understanding the life cycle, the chemistry that actually belongs to wild sclerotia, and the documented kidney harm from high-dose powder matters more than another antioxidant leaderboard.
What is chaga, if it is not a mushroom cap?
Chaga is the sterile sclerotium of Inonotus obliquus, a charcoal-black, deeply cracked lump that bursts through living birch bark and hides a corky, rusty-orange interior. There is no pore surface on the lump you harvest. There are no gills, no stem, and no spores in that tissue. Michael Kuo’s account on MushroomExpert still gives the cleanest field picture: irregular outline, surface broken into dry cubes, flesh tough and orange-brown, KOH flashing instantly black on the context.
The sexual stage is a different organ. After years or decades of heart-rot, the host dies. Then a thin, resupinate pore sheet forms under the bark of the snag or log, often above the old conk, with pores set at an oblique angle to the trunk — the reason Fries called the fungus obliquus. Field literature puts that fruiting event at roughly once per infection cycle, and the cycle itself can run for decades. The pore surface is annual, quickly wrecked by insects and weather, and easy to miss. A public-domain scan of one Finnish collection, made by Olli Niemitalo, sits on Wikimedia Commons.
Older names you will meet on herbarium labels include Boletus obliquus, Polyporus obliquus, Poria obliqua, Fomes obliquus, and Phellinus obliquus. Those are synonyms of one concept, not a stack of lookalikes. Whether circumboreal populations are a single species or a quiet complex is still an open question. No published revision has split them.
How can you tell wild chaga from burls and look-alike conks?
Reliable field identification of chaga depends on host, surface, and interior together, not on a black lump seen from the trail. The fungus grows mainly on living Betula. The exterior is melanized, dry, and broken into charcoal cubes. Break or cut a piece and the inside should be corky gold to rusty orange, without an organized tube layer. If you can find a pore surface on the underside of the lump, you are not holding chaga. You are holding a real conk, often a Phellinus.
Burls fool people from twenty feet. They are swollen wood. Grain runs through them. The interior is pale wood, not orange fungal cork. Wound callus on cherry, oak, or aspen is the same mistake in a different genus. Phellinus igniarius, P. tremulae, and their relatives can look black and cracked at a glance, but they are hard woody brackets with a brown pore layer underneath and rusty-brown context.
Field identification vs. confirmation:
- Field-likely: living or recently living birch, cracked black crust, orange corky interior, no pores on the mass.
- Needs more: any host that is not birch, any mass with a pore surface, any interior that is woody or pale.
- Confirmation tools for the rare sexual stage: hymenial setae, broadly ellipsoid spores in the range reported by Gilbertson and later authors, and, when the collection is odd, DNA.
Photographs alone do not close the ID. A checklist does not make a tea safe.
Where does Inonotus obliquus live, and what does it do to the tree?
Inonotus obliquus occupies the circumboreal belt wherever birch is common. The 2025 IUCN assessment by Else Vellinga rates the species Least Concern across Canada, the northern United States, Fennoscandia, much of Europe with birch, and the Russian Federation. NatureServe treats the same taxon as globally secure and notes that mapping is still incomplete.
Infection starts when basidiospores land in an unhealed wound — frost crack, branch stub, beetle gallery. The fungus colonizes heartwood, strips lignin, and builds the external sclerotium at the original breach. A tree can carry a visible conk for ten or twenty years and still leaf out. Timber value falls because of the hidden white rot. When the tree finally dies, the fungus fruits under bark and the next wounded birch receives the spores.
Host is not a footnote for chemistry. A 2024 paper in Pharmaceuticals by Ain Raal and colleagues compared conks from Betula pendula and B. pubescens. Both carried inotodiol, lanosterol, betulin, and betulinic acid. The B. pendula extracts ran somewhat higher in inotodiol and were somewhat more cytotoxic to several cancer cell lines in vitro. A 2023 Molecules study led by Katarzyna Sułkowska-Ziaja found betulin and betulinic acid highest in a B. pendula isolate and much lower in an isolate taken from alder. Geography, host, and age of the mass all move the numbers.
Did chaga simply steal its chemistry from birch bark?
Chaga did not become chemically interesting by sitting still and sipping birch sap. The usual story is that betulin and betulinic acid in the conk are borrowed wholesale from bark. Birch bark is, in fact, loaded with those lupane triterpenes. The fungus living inside that bark was assumed to be a sponge.
A 2025 genome paper in Scientific Reports changes the frame. Omid Safronov and colleagues at the University of Helsinki assembled a 50.7 Mbp PacBio genome and dated a lineage-specific whole-genome duplication to about 1.3 million years ago. After that duplication the fungus kept extra cytochrome P450 genes and further expanded secondary-metabolism clusters by tandem copies. Metabolomic fingerprinting showed a more complex terpene profile than in related species that never doubled their genomes. Birch itself evolved high bark betulin earlier, about 4 to 8 million years ago. A candidate fungal CYP716-like enzyme did not perform plant-style betulin synthesis. Conserved P450 domains also argue against a simple gene theft from the host.
The working picture is co-evolution, not theft. The fungus lives in birch, it handles birch compounds, and it also built its own expanded toolkit. HPLC in the same paper found chaga strains richer in betulinic acid relative to betulin — the opposite ratio of the host bark. Other labs still recover little or no betulin in some wild cankers. That is why a 2025 multi-method survey in the International Journal of Molecular Sciences warned that betulin and betulinic acid are unreliable authenticity markers. The markers that did separate real sclerotia from grain fermentations were the lanostanes — inotodiol, trametenolic acid, lanosterol — plus melanin absorbance and the absence of starch.
Several authors of that authenticity paper work for a company that sells wildcrafted chaga. The methods are public. The conflict belongs next to the finding, not behind it. The practical implication does not depend on the brand: a jar of mycelium grown on rice is not a twenty-year birch sclerotium.
How was chaga used before it became a supplement aisle?
The cleanest primary record for western Siberia is still Maret Saar’s 1991 paper in the Journal of Ethnopharmacology. Among a short list of fungi the Khanty actually used, I. obliquus appears as tea, smoke, and wash water. Later reviews, including the 2023 survey by Eric Fordjour and colleagues in Frontiers in Pharmacology, summarize those practices without turning them into a modern dosing guide. Saar’s work is interview-based and modest. It does not support the sentence “Siberians drank chaga and never got cancer.”
North American oral traditions tie the conk to birch and to fire. Cree and other Algonquian stories about Wisakecak throwing a scab or scrap of meat onto a birch are living narrative, not a dated chronicle entry. Treat them that way.
The Vladimir Monomakh lip-tumor tale is the most repeated European anecdote and the least anchored. Russian herbal sites cite “the chronicles.” Historians checking the Laurentian text of the Primary Chronicle and Monomakh’s Testament have not found the cure. A 2023 H-Net thread among Slavicists treats it as later legend. State it as folklore.
Finland is on firmer wartime ground as a coffee culture under blockade. Pakurikääpä was one of several roasted forest substitutes when beans disappeared. Official ration tables list coffee and tea substitutes in grams. They do not make chaga a secret weapon. People in birch country already knew the conk. When the pantry emptied, they boiled what they had.
Alexander Solzhenitsyn’s Cancer Ward later gave the fungus a literary second life. A character dreams of disappearing into the woods to break chaga, boil it, and get well “like an animal.” That is fiction informed by camp talk, not a trial.
What compounds are actually in the sclerotium?
Reviews now catalog more than two hundred secondary metabolites from I. obliquus. A few families do the real work.
Lanostane triterpenoids are the chemical signature of authentic sclerotia in current authenticity work. Inotodiol is often the most abundant measured lanostane, with trametenolic acid, lanosterol, and 3β-hydroxylanosta-8,24-dien-21-al close behind. These are fungal sterol relatives, not birch lupanes. In vitro they show cytotoxicity in selected cancer cell lines. A 2024 Biomolecules paper reported that several of them inhibit dihydrofolate reductase and can act with cisplatin or trastuzumab in breast-cancer cell models. That is laboratory mechanism. It is not a treatment claim.
Lupane triterpenes — betulin and betulinic acid — appear in many wild collections and in some cultured isolates, especially from birch hosts. Amounts swing hard by geography and method. Treat them as present-and-variable, not as a guaranteed label number.
Polysaccharides, including β-glucans, are the water-soluble fraction people chase with long decoctions. Structure differs by source. A 2021 comparison in Journal of Fungi of cultivated mycelium, sterile conk, and birch heart-rot found mycelial glucans in higher-molecular-weight populations, conk glucans smaller and more uniform, and heart-rot extracts dominated by plant hemicelluloses with some fungal polysaccharide mixed in. Phenolics rode along with the wild conk fractions and were absent from the mycelial polysaccharide fractions in that study.
Melanin in the black crust is a genuine ecological adaptation — ultraviolet screen, radical sink, armor — and one reason dual extraction exists. Chitin in the cell walls is indigestible to humans. Raw grated sclerotium is a poor delivery system for anything locked behind those walls.
Superoxide dismutase is the marketing enzyme. Peer-reviewed papers do not supply the “35,000 units per gram” figure that circulates on sales pages. Even if the protein were abundant, swallowed SOD is a protein. The gut dismantles proteins.
ORAC scores belong in the same bin. The USDA Nutrient Data Laboratory withdrew its ORAC database in 2012 because test-tube radical absorbance was being used to sell food, and because those numbers have no established relationship to human health outcomes. A “50,000 ORAC” chaga claim is a relic of that race, often compared against fresh blueberries as if powder and fruit were the same serving.
Evidence, stated plainly:
- Established: identity as a birch-associated hymenochaetaceous white-rot fungus; sclerotium versus rare resupinate fruiting body; high oxalate load in powder; presence of lanostane triterpenoids and melanin in wild sclerotia.
- Well supported in vitro and in animals: antioxidant assays, anti-inflammatory pathway effects, cytotoxicity of inotodiol and related triterpenes in cell lines, glucose-lowering in diabetic rodent models, a platelet-inhibitory tripeptide (Trp-Gly-Cys) isolated from mycelial ethanol extract in 2006.
- Proposed: useful adjunct activity in oncology or metabolic disease in humans; standardized dual extracts as drugs.
- Uncertain or unsupported as stated: highest ORAC food on earth, SOD megadoses, guaranteed anticancer tea, grain-grown mycelium as chemical equivalent of wild conk.
Nicholas Money’s 2016 essay “Are mushrooms medicinal?” in Fungal Biology remains useful cold water. Secondary metabolites with pharmacology exist in fungi. That is not the same as evidence that a supermarket extract treats human disease. The gap has narrowed only a little: more mechanism papers, still almost no rigorous clinical trials of chaga itself.
Is chaga mushroom safe?
Chaga is not harmless tea bark. The harm that has reached hospitals is oxalate.
In 2014, Yuko Kikuchi and colleagues described oxalate nephropathy in a 72-year-old Japanese woman who had taken several teaspoons of powder daily for months after liver-cancer surgery. In 2020, Sua Lee and colleagues reported a 49-year-old Korean man who reached end-stage renal disease after years of powder for atopic dermatitis. The leftover material in that case measured 14.2 g oxalate per 100 g. Estimated intake ran two to five times a typical dietary oxalate load. Biopsy showed chronic tubulointerstitial nephritis with oxalate crystals. He stayed on dialysis.
In 2022, Ohyun Kwon and colleagues published in Medicine the case of a 69-year-old man who took 10 to 15 g of powder daily plus 500 mg of vitamin C for three months to “boost immunity.” He arrived with acute kidney injury and nephrotic-range protein. Biopsy showed calcium oxalate in tubules, focal tubular injury, and foot-process effacement of podocytes — oxalate nephropathy plus minimal change disease. Function recovered after dialysis and high-dose steroids, which is luck, not a plan.
Vitamin C matters here because ascorbate can metabolize to oxalate. Pairing megadose chaga powder with extra vitamin C is a specifically bad combination.
Other cautions rest on weaker human data and should still change behavior:
- A 2006 paper in Peptides isolated a Trp-Gly-Cys tripeptide from mycelial extract that inhibited platelet aggregation in vitro and in mice. Human bleeding events are not well documented, but anyone on warfarin, DOACs, or dual antiplatelet therapy, or anyone booked for surgery, should treat concentrated chaga as a theoretical bleeding risk and ask a clinician.
- Rodent work, including a 2025 Journal of Ethnopharmacology study of betulinic acid from I. obliquus in db/db mice, supports a glucose-lowering effect. People on insulin or sulfonylureas should not add a concentrated extract and guess.
- Pregnancy and lactation have no adequate human safety data.
- Autoimmune disease and immunosuppressants sit in the theoretical pile. β-glucans are biological response modifiers. That can be unwanted.
None of this is a reason to panic over a weak traditional decoction taken occasionally by a person with healthy kidneys. It is a reason to treat 10 g per day of powder as a drug-like exposure.
How should chaga be prepared, and what is actually in the jar?
Traditional preparation is a long hot-water decoction of broken sclerotium. Water pulls polysaccharides and some phenolics. Alcohol pulls triterpenoids. Dual extraction exists because the chemistry is split.
Label reading is now an analytical problem. The 2025 complementary-methods study already cited found whole wild canker and honest 1:1 extracts carrying inotodiol and trametenolic acid, while several mycelium-on-grain products were starch-positive, triterpenoid-poor, and chemically closer to fermented cereal than to a birch conk. Melanin absorbance helped separate the groups. Ergosterol helped separate fungus from grain but did not separate mycelium from sclerotium by itself.
“100% mushroom” on a chaga jar is often false in two directions at once. The sclerotium is not a mushroom, and the jar may not even be sclerotium.
Sustainable harvest is a local ethics problem more than a global extinction problem. IUCN rates the species Least Concern because the fungus is widespread where birch is widespread. Individual large sclerotia still take years to become harvestable. Cutting into the cambium to pry a mass free opens a wound. Leaving a portion on a living tree is common advice from conscientious foragers. Regrowth is real and uneven. Taking every visible conk in a stand is how a public forest loses its chaga for a decade. Harvest from dead trees is a different product: the fungus has already shifted toward fruiting, and some fractions have begun to degrade.
Industrial uses — ligninolytic enzymes for dye and pesticide breakdown, experimental biofertilizers, β-glucans in feed — are real research lines summarized in the Fordjour review. They are not reasons to drink more tea.
How does chaga compare with the other fungi people actually buy?
Reishi is a true woody fruiting body with its own triterpenoid set and a larger, still uneven clinical literature. Lion’s mane is a fleshy fruiting body whose interesting molecules live in different tissues depending on whether you bought fruiting body or mycelium. Turkey tail is a thin annual polypore whose PSK and PSP fractions went through oncology trials in Japan. Chaga is the outlier: a sterile canker whose best-supported human toxicology is kidney injury from oxalate, and whose best-supported chemistry is a wild, host-shaped lanostane profile that grain bags do not reproduce.
If the goal is β-glucans, several cultivated species deliver them more honestly. If the goal is inotodiol, you need authentic sclerotium and an extract method that dissolves triterpenes. If the goal is “adaptogen coffee,” you are shopping a flavor and a story.
Wild birch sclerotium → Grain-grown “chaga” mycelium
How to distinguish them: Real sclerotium is orange-cork inside a black crust and carries lanostanes such as inotodiol. Grain products often test positive for starch, lack that triterpenoid fingerprint, and look like fermented cereal under complementary assays.
Chaga sclerotium on birch → Phellinus conk or tree burl
How to distinguish them: Flip the lump. A Phellinus has a real pore layer and hard rusty context. A burl is swollen wood with grain, not orange fungal cork. Chaga has no pores on the harvested mass and lives mainly on birch.
Raw chaga powder → Dual-extracted sclerotium
How to distinguish them: Raw powder still contains chitin walls and a heavy oxalate load. Dual extraction is a two-solvent attempt to pull water-soluble glucans and alcohol-soluble triterpenes. Neither format is a licensed drug.
10 Cool Facts About Chaga
- The object in the tea is sterile. Spores come from a different organ, years later, under dead bark.
- That sexual fruiting body may appear only once in an infection lasting several decades.
- A Helsinki team dated a chaga-specific whole-genome duplication to about 1.3 million years ago and tied it to extra P450 genes.
- Birch beat the fungus to betulin by several million years. The fungus then evolved overlapping chemistry on its own.
- KOH on the orange flesh flashes black — a field chemical test, not a wellness ritual.
- Finnish wartime coffee culture used pakurikääpä as one of many substitutes when beans vanished. It was pantry improvisation, not a classified ration.
- The Monomakh lip-cancer story does not appear in the Primary Chronicle texts historians actually read.
- One measured powder hit 14.2 g oxalate per 100 g — enough, at high daily grams, to crystallize in human tubules.
- Inotodiol, not betulin, is the triterpene authenticity studies keep finding in real sclerotia and missing in grain products.
- IUCN still calls the species Least Concern. Your favorite roadside birch can still be picked clean.
Frequently Asked Questions
Is the black lump on a birch the actual mushroom?
No. The familiar black mass is a sterile sclerotium of Inonotus obliquus. The sexual fruiting body forms later, usually once, as a thin pore sheet under the bark of a dead host, and most people never see it.
Does chaga just absorb betulin from birch?
Not as a sponge. Birch bark is rich in betulin, and some of that chemistry shows up in the fungus, but the 2025 genome study shows I. obliquus independently expanded its own terpene and P450 toolkit after a whole-genome duplication.
Is grain-grown chaga the same product?
No. Multi-method testing in 2025 found fermented-grain products lacking the lanostane fingerprint of wild sclerotia and often testing positive for starch. Mycelium is not a twenty-year birch canker.
Who should not use chaga powder?
Anyone with kidney disease, a history of oxalate stones, or unexplained renal impairment. Also pause before surgery, and be cautious with anticoagulants, insulin or sulfonylureas, pregnancy, and immunosuppressants. Occasional weak tea is not the same exposure as 10 g of powder a day.
Is chaga endangered?
The species is Least Concern on the 2025 IUCN assessment because it is widespread in birch country. Local overharvest of large sclerotia is still a real forest-ethics problem.
Can you cook the oxalate out?
No. Oxalate is not an amatoxin story with a different ending. High-dose powder remains a kidney problem whether you simmer it or swallow it dry. Dose and duration are the variables that have landed people in hospital.
Glossary
- Basidiospore: A sexual spore produced on a basidium; in this species, the inoculum that starts a new birch infection.
- Betulin / betulinic acid: Lupane triterpenes abundant in birch bark and variably present in chaga; poor standalone authenticity markers.
- Dual extraction: Sequential hot-water and alcohol extraction used to capture both polysaccharides and triterpenoids.
- Hymenochaetaceae: The polypore family that includes Inonotus and many rusty-brown wood decayers.
- Inotodiol: A lanostane triterpenoid that current chemical surveys treat as a leading marker of authentic sclerotium.
- Lanostane triterpenoid: A fungal sterol-related skeleton; the group that includes inotodiol, trametenolic acid, and lanosterol in chaga.
- Melanin: Dark polymer concentrated in the sclerotium crust; ecological ultraviolet and radical protection.
- Oxalate nephropathy: Kidney injury from calcium oxalate crystals in tubules; the documented clinical harm from high-dose chaga powder.
- Resupinate: A fruiting body spread flat on the substrate rather than forming a cap or bracket; the sexual stage of I. obliquus.
- Sclerotium: A hardened storage mass of mycelium; the harvested “chaga.”
- White rot: Wood decay that degrades lignin and often cellulose, bleaching the wood; the ecological mode of I. obliquus.
- Whole-genome duplication: A lineage event in which the entire genome is copied; dated to about 1.3 million years ago in this fungus and linked to extra P450 genes.
Bibliography
Fordjour, E., Manful, C. F., Javed, R., Galagedara, L. W., Cuss, C. W., Cheema, M., and Thomas, R. “Chaga mushroom: a super-fungus with countless facets and untapped potential.” Frontiers in Pharmacology 14 (2023): 1273786. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1273786/full
GBIF Secretariat. Inonotus obliquus (Fr.) Pilát. Catalogue of Life / GBIF, 2026. https://www.gbif.org/taxon/3PS3N
H-Net. “Vladimir Monomakh’s mushrooms.” Discussion thread, 2023. https://networks.h-net.org/node/3076/discussions/12886719/vladimir-monomakhs-mushrooms
Hyun, K. W., Jeong, S. C., Lee, D. H., Park, J. S., and Lee, J. S. “Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus.” Peptides 27, no. 6 (2006): 1173–1178. https://pubmed.ncbi.nlm.nih.gov/16289471/
Index Fungorum. Inonotus obliquus (Fr.) Pilát. Record ID 315905. https://www.indexfungorum.org/Names/NamesRecord.asp?RecordID=315905
Journal of Ethnopharmacology. “Betulinic acid from Inonotus obliquus ameliorates T2DM by modulating short-chain fatty acids producing bacteria and amino acids metabolism in db/db mice.” 342 (2025): 119417. https://pubmed.ncbi.nlm.nih.gov/39884483/
Journal of Fungi. “Comparison of polysaccharides extracted from cultivated mycelium of Inonotus obliquus with polysaccharide fractions obtained from sterile conk (chaga) and birch heart rot.” 7, no. 3 (2021): 189. https://www.mdpi.com/2309-608x/7/3/189
Kikuchi, Y., et al. “Chaga mushroom-induced oxalate nephropathy.” Clinical Nephrology 81, no. 6 (2014): 440–444. https://pubmed.ncbi.nlm.nih.gov/23149251/
Kuo, M. “Inonotus obliquus.” MushroomExpert.Com. https://www.mushroomexpert.com/inonotus_obliquus.html
Kwon, O., Kim, Y., Paek, J. H., Park, W. Y., Han, S., Sin, H., and Jin, K. “Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report.” Medicine 101, no. 10 (2022): e28997. https://pmc.ncbi.nlm.nih.gov/articles/PMC8913114/
Lee, S., Lee, H. Y., Park, Y., et al. “Development of end stage renal disease after long-term ingestion of Chaga mushroom: Case report and review of literature.” Journal of Korean Medical Science 35, no. 19 (2020): e122. https://pmc.ncbi.nlm.nih.gov/articles/PMC7234858/
Money, N. P. “Are mushrooms medicinal?” Fungal Biology 120, no. 4 (2016): 449–453. https://www.sciencedirect.com/science/article/pii/S1878614616000180
NCBI Taxonomy. Inonotus obliquus. Taxid 167356. https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=167356
NatureServe. Inonotus obliquus. https://explorer.natureserve.org/Taxon/ELEMENT_GLOBAL.2.912081
Niemitalo, O. “Chaga fruiting body sample.” Photograph, CC0. Wikimedia Commons, 2017. https://commons.wikimedia.org/wiki/File:Chaga_fruiting_body_sample.png
Raal, A., Kaldmäe, H., Kütt, K., et al. “Chemical content and cytotoxic activity on various cancer cell lines of chaga (Inonotus obliquus) growing on Betula pendula and Betula pubescens.” Pharmaceuticals 17, no. 8 (2024): 1013. https://pmc.ncbi.nlm.nih.gov/articles/PMC11357148/
Saar, M. “Fungi in Khanty folk medicine.” Journal of Ethnopharmacology 31, no. 2 (1991): 175–179. https://pubmed.ncbi.nlm.nih.gov/2023426/
Safronov, O., Bal, G. L., Sipari, N., et al. “Independent evolution of betulin biosynthesis in Inonotus obliquus.” Scientific Reports 15 (2025): 21319. https://www.nature.com/articles/s41598-025-05414-1
Sułkowska-Ziaja, K., Robak, J., Szczepkowski, A., et al. “Comparison of bioactive secondary metabolites and cytotoxicity of extracts from Inonotus obliquus isolates from different host species.” Molecules 28, no. 13 (2023): 4907. https://www.mdpi.com/1420-3049/28/13/4907
USDA Agricultural Research Service, Nutrient Data Laboratory. Withdrawal of the ORAC database. Archived statement, 2012. https://web.archive.org/web/20160809070306/http:/www.ars.usda.gov/Main/docs.htm?docid=6233
Vellinga, E. C. “Inonotus obliquus.” The IUCN Red List of Threatened Species, 2025. https://redlist.info/iucn/species_view/315905/
Wang, J., et al. “Chaga mushroom triterpenoids inhibit dihydrofolate reductase and act synergistically with conventional therapies in breast cancer.” Biomolecules 14, no. 11 (2024): 1454. https://pubmed.ncbi.nlm.nih.gov/39595631/
Wikimedia Commons. Category: Inonotus obliquus. https://commons.wikimedia.org/wiki/Category:Inonotus_obliquus
Windsor, C., Kreynes, A. E., Chilton, J. S., Chioffi, W. A., Krishnamurthy, A., and Ishii, M. “Comparative study of chaga (Inonotus obliquus) dietary supplements using complementary analytical techniques.” International Journal of Molecular Sciences 26, no. 7 (2025): 2970. https://pmc.ncbi.nlm.nih.gov/articles/PMC11988691/
Freshness Date: August 31, 2026
Items Needing Future Review:
- Watch for a multilocus or phylogenomic paper that splits or confirms circumboreal I. obliquus.
- Track any registered randomized trial of a chemically characterized chaga extract with a hard clinical endpoint.
- Update oxalate guidance if a larger case series or regulator warning appears.
- Revisit cultivation claims when a method demonstrates lanostane profiles matching wild sclerotia.